GT Biopharma Inc GTBP
NASDAQ · United States · Health Technology
$6.30+0.10 (+1.61%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-14 | -3.00 | -2.00 | -50.0% | $0 | — | -4.0%$0.30→$0.28 |
| Q1 2026 | 2026-05-15 | -2.75 | -2.00 | -37.5% | — | — | -17.1%$0.44→$0.36 |
| Q4 2025 | 2026-03-02 | -121.00 | -5.50 | -2,100.0% | — | — | -1.7%$0.48→$0.47 |
| Q3 2025 | 2025-11-14 | -20.75 | -9.50 | -118.4% | — | — | -5.9%$0.73→$0.69 |
| Q2 2025 | 2025-08-14 | -13.75 | -17.00 | +19.1% | — | — | — |
| Q1 2025 | 2025-05-15 | -8.25 | -16.00 | +48.4% | — | — | — |
| Q4 2024 | 2025-02-21 | -41.50 | -38.75 | -7.1% | — | — | — |
| Q3 2024 | 2024-11-14 | -38.25 | -67.50 | +43.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.